| Current Price | $158.34 | Mkt Cap | $19.7B |
|---|---|---|---|
| Open | $156.74 | P/E Ratio | 46.69 |
| Prev. Close | $156.53 | Div. (Yield) | $4.12 (2.6%) |
| Daily Range | $156.74 - $159.21 | Volume | 23,963 |
| 52-Wk Range | $109.22 - $177.70 | Avg. Daily Vol. | 716,017 |
The Company is engaged principally in the ownership, operation, management, selective redevelopment, development and acquisition of properties for the life sciences industry.
| Current Price | $158.34 | Mkt Cap | $19.7B |
|---|---|---|---|
| Open | $156.74 | P/E Ratio | 46.69 |
| Prev. Close | $156.53 | Div. (Yield) | $4.12 (2.6%) |
| Daily Range | $156.74 - $159.21 | Volume | 23,963 |
| 52-Wk Range | $109.22 - $177.70 | Avg. Daily Vol. | 716,017 |
The best Bull and Bear pitches based on recency and number of recommendations.
Alexandria Real Estate Equities (ARE) is the largest “life science” real estate company, serving major pharmaceutical, biotech, and medical sciences industries. At the end of 2012, ARE owned 178 properties, covering about 17 million rent-able square… More
Expensive property in a niche market for life science research seems to be a bit speculative in this market, especially given that some of these properties are in cities like SF, where prices continue to fall as taxes continue to rise.
Read the most recent pitches from players about ARE.
Recs
RowdyCat
(87.69)
Submitted: 2/9/2020 11:40:48 AM :
Start Price:
$166.10
NYSE:ARE Score:
-2.51
This pick gets exposure to the biotech/pharma industries without investment in a specific company. Rather, ARE is a REIT that builds out laboratory space for up and coming companies.
Recs
aetel
(77.97)
Submitted: 3/13/2019 8:32:46 PM :
Start Price:
$134.62
NYSE:ARE Score:
+2.37
Growing company with a goal-driven leader taking a fresh approach towards targeting a growing sector that will continue to stay relevant and elemental to the evolution of mankind. Textbook approach applying the concept of skill clustering and playing off the needs of a specialized field with unique demands.
Watch for the falter in public, private and governmental support of research and funding of Biotech, Agtech and health research.
Recs
SolelyOnWhaIHear
(80.25)
Submitted: 3/7/2019 2:04:43 AM :
Start Price:
$131.29
NYSE:ARE Score:
+3.46
Bio cluster
Find the members with the highest scoring picks in ARE.
SSPX3 (< 20) Score: +350.37
The Score Leader is the player with the highest score across all their picks in ARE.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| SSPX3 | < 20 | 5/14/2009 |
|
NS | $21.88 | +615.34% | +264.97% | +350.37 | 0 Comment | |
| czarl | 58.37 | 5/27/2009 |
|
NS | $24.95 | +527.49% | +254.14% | +273.35 | 0 Comment | |
| crabbucket1 | < 20 | 5/4/2009 |
|
3M | $24.93 | +527.84% | +265.69% | +262.14 | 1 Comment | |
| TraderJFH | 96.66 | 7/22/2009 |
|
1Y | $26.27 | +495.92% | +236.35% | +259.57 | 0 Comment | |
| mitchiemono | 76.07 |
|
|
3Y | $25.52 | +513.42% | +277.95% | +235.47 | 0 Comment | |
| NSHanlon | 52.11 | 4/27/2009 |
|
3Y | $25.52 | +513.42% | +277.95% | +235.47 | 0 Comment | |
| Lance03 | 23.83 | 3/9/2009 |
|
NS | $22.33 | +601.04% | +379.94% | +221.10 | 0 Comment | |
| SSPXXX | < 20 | 6/8/2009 |
|
5Y | $28.44 | +450.40% | +245.06% | +205.34 | 0 Comment | |
| TMFMattyA | 99.91 | 9/17/2013 |
|
5Y | $50.60 | +209.35% | +87.38% | +121.98 | 1 Comment | |
| BaseBawl | < 20 | 10/4/2013 |
|
5Y | $51.10 | +206.33% | +90.44% | +115.89 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
